Carmine Dario Vizza

Pubblicazioni

Titolo Pubblicato in Anno
Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE). a multicentre, open-label, randomised controlled trial THE LANCET RESPIRATORY MEDICINE 2021
Pulmonary hypertension in patients with COPD. results from the comparative, prospective registry of newly initiated therapies for pulmonary hypertension (COMPERA) CHEST 2021
Medical treatment of pulmonary hypertension in adults with congenital heart disease. updated and extended results from the International COMPERA-CHD registry CARDIOVASCULAR DIAGNOSIS AND THERAPY 2021
Right ventricular assessment matters for precision medicine. Reply to "Identifying parameters associated with response to switching from a PDE5i to riociguat in RESPITE" INTERNATIONAL JOURNAL OF CARDIOLOGY 2021
COMPERA 2.0: A refined 4-strata risk assessment model for pulmonary arterial hypertension EUROPEAN RESPIRATORY JOURNAL 2021
ECMO Assistance during Mechanical Ventilation. effects Induced on energetic and haemodynamic variables COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE 2021
Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension. final safety data from the EXPERT registry RESPIRATORY MEDICINE 2021
Incidence and long-term outcomes of pregnant women complicated with pulmonary arterial hypertension during different pregnancies. a prospective cohort study from china INTERNATIONAL JOURNAL OF CARDIOLOGY 2021
Right ventricular strain in pulmonary hypertension looking at the small print reply JACC. CARDIOVASCULAR IMAGING 2021
Chronic thromboembolic pulmonary hypertension risk score evaluation and validation (CTEPH Solution): proposal of a study protocol aimed to realize a validated risk score for early diagnosis MINERVA CARDIOLOGY AND ANGIOLOGY 2021
Clinical implications of idiopathic pulmonary arterial hypertension phenotypes defined by cluster analysis THE JOURNAL OF HEART AND LUNG TRANSPLANTATION 2020
Usefulness of adding echocardiography of the right heart to risk-assessment scores in prostanoid-treated pulmonary arterial hypertension JACC: CARDIOVASCULAR IMAGING 2020
Intra-aortic balloon counterpulsation timing: A new numerical model for programming and training in the clinical environment COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE 2020
Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry THE JOURNAL OF HEART AND LUNG TRANSPLANTATION 2020
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension ARTHRITIS RESEARCH & THERAPY 2020
Long-term study of oral treprostinil to treat pulmonary arterial hypertension. dosing, tolerability, and pharmacokinetics PULMONARY CIRCULATION 2020
Pulmonary hypertension in adults with congenital heart disease. real-world data from the International COMPERA-CHD registry JOURNAL OF CLINICAL MEDICINE 2020
Risk reduction and right heart reverse remodeling by upfront triple combination therapy in pulmonary arterial hypertension CHEST 2020
Imaging risk in pulmonary arterial hypertension EUROPEAN RESPIRATORY JOURNAL 2020
Hemodynamics and risk assessment 2 years after the initiation of upfront ambrisentan‒tadalafil in pulmonary arterial hypertension. THE JOURNAL OF HEART AND LUNG TRANSPLANTATION 2020

Progetti di Ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma